BCS2: Reformulating the Future of Medicine

BCS2 is addressing a fundamental truth: while tablets and capsules are convenient, they are often the least effective way to deliver life-saving medicine. We are dedicated to turning "brick dust" molecules into high-performance treatments that work faster and better for every patient.

The Challenge

The pharmaceutical industry faces a quiet crisis of inefficiency.

The Solubility Barrier: Over 40% of current drugs and 90% of new candidates are poorly soluble, leading to wasted efficacy.
The Metabolism Barrier: Standard tablets are often destroyed by the liver before they can ever reach the bloodstream.
The Delivery Gap: Up to 60% of older populations struggle to swallow traditional tablets, leading to dangerous non-compliance.

The BCS2 Solution

We use AI-driven "Super Generic" engineering to rescue intractable drugs and maximize their potential.

Simple Solvents

Non-toxic, non-organic solvents like aqueous-based systems and certain inorganic liquids utilize natural hydration and ionic interactions to effectively dissolve poorly soluble active pharmaceutical ingredients. By avoiding harsh synthetic chemicals, these green alternatives provide a biocompatible delivery medium that enhances drug absorption while ensuring a superior safety profile for the patient.

Patient-First Formulations

By bypassing the stomach and liver, our delivery methods offer immediate action and high consistency

Oral Sprays & Films: Rapid absorption through the mouth.
Nasal Mists: Direct-to-brain delivery for complex conditions.
Lymphatic Targeting: Smarter routes for lipophilic compounds.

At BCS2, we use a proprietary AI platform to solve the pharmaceutical industry’s biggest challenge: drug solubility. By replacing slow, manual lab trials with high-speed digital modeling, our AI predicts the perfect solvent match for "unsolvable" drugs—increasing their effectiveness